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Surgical Techniquesthrough the third intercostal space. The device was covered
with a polytetrafluoroethylene (Gore-Tex) mesh to mini-
mize lung adhesions.
For 7 cases, bypass times ranged from 68 to 136 minutes.
Intraoperative blood product use ranged from 0 to 3 units of
red blood cells, 2 to 3 units of fresh frozen plasma, and 1 to 2
pooled platelet units. Preoperatively, all patients had at least
moderate RV dysfunction determined by cardiac magnetic
resonance imaging (RV ejection fraction range, 20%-
35%). Yet, postoperative RV failure did not develop in
any of the patients. Four patients were extubated between
12 and 24 hours after surgery. The other 3 patients were ex-
tubated on postoperative days 2, 5, and 7.
DISCUSSION
As LVAD support for patients with heart failure becomes
increasingly popular, concern for redo sternotomies
increases.4 Further, reoperative sternotomy at the time of
subsequent heart transplantation has been associated with
decreased short- and long-term survival. To avoid redo
sternotomy, new methods of LVAD implantation must be
explored, particularly as new-generation devices become
smaller and more conducive to minimally invasive implan-
tation. Our approach improves on existing less-invasive
approaches for LVAD implantation because robotic
technology provides optimal visualization for RV
dissection and reduced risk of kinking the outflow graft.5
Performing the anastomosis of the graft to the ascending
aorta through right chest ports further decreases mediastinal
dissection. This may improve outcomes in these patients atFrom the Division of Cardiac Surgery, Brigham and Women’s Hospital, Boston,
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The Journal of Thoracic and Carthe time of transplantation. Furthermore, the robotic ports
discussed are suitable for concomitant procedures usually
performed through the right chest.CONCLUSIONS
Refinements in surgical technique, teamdevelopment and
training methods, and patient selection and management
will enable robotic technology to play an important role
in LVAD implantation.
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using a Codman MicrosensorIgor Gosev, MD, Leacche Marzia, MD, Robert C. Neely, MD, and Gregory S. Couper, MD, Boston, MassVentricular assist devices have become an important
element for the treatment of advanced heart failure.1 Since
2006, more than 6000 mechanical assist devices have been
implanted in patients in the United States.2 In 2008, thesecond-generation axial flow HeartMate II (Thoratec
Corp, Pleasanton, Calif) pump was approved by the Food
and Drug Administration as a bridge to transplant therapyFIGURE 1. Assembled left atrial line.
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FIGURE 2. Placement of the left atrial line through the abdominal wall. FIGURE 4. Microsensor transducer passed through a 5F guiding catheter
and secured with a rotating hemostatic valve.
Surgical Techniquesand in 2010 as a destination therapy for patients not eligible
for heart transplantation.3,4CLINICAL SUMMARY
Successful early and late survival depend on multiple
perioperative factors. Accurate measurement of preload to
the right ventricle and left ventricle (LV) is one of the
main parameters that guide therapy in the early postopera-
tive course. Right-sided heart failure can occur during
significant unloading of the LV with the HeartMate II de-
vice because of an intraventricular septal shift to the left
in systole and decreased right ventricular output.5 Thus, ac-
curate and preferably continuous assessments of right atrial
(RA) and left atrial (LA) pressures are extremely important.
RA pressure is obtained from the central venous line
placed in the right atrium or from the RA port of the
Swan–Ganz catheter. LA pressure may be indirectly
estimated using pulmonary artery diastolic pressure, but
this method may be inaccurate in the presence of increased
pulmonary vascular resistance.6 Using pulmonary capillary
wedge pressure as a surrogate for LA pressure is more
labor-intensive and yields only intermittent values. Direct
measurement of LA pressure with regular fluid-filled
pressure tubing used on the right side is reliable but carries
the risk of air embolism or bleeding during removal.
We describe a novel way of directly measuring LA
pressure using a Codman Microsensor (DePuy Co,
Raynham, Mass) and pressure wire, a technique routinely
used for measuring intracranial pressure.
Between February 2010 and December 2012 at Brigham
and Women’s Hospital, 61 patients underwent implantation
of the HeartMate II device with the concomitant use of aFIGURE 3. Position of the left atrial line within the pericardium.
1426 The Journal of Thoracic and Cardiovascular SurCodman LA pressure monitoring system. After partial divi-
sion of the left diaphragm and formation of the HeartMate
II device pocket and before heparinization and cardiopulmo-
nary bypass initiation, a pledgeted Ethibond (Ethicon, Som-
erville, NJ) 2-0 mattress suture is placed in the right superior
pulmonary vein. An LA pressure catheter is then inserted in
the same fashion as fluid-filled catheters, except a critical
step of zeroing the Microsensor transducer is done before
insertion. During the preparation for insertion, aMicrosensor
transducer is passed through a 5F guiding catheter and
secured with a rotating hemostatic valve. The catheter is
passed through the abdominal wall, zeroed, and then inserted
into the LA through the madras suture that is secured around
the catheter, but not too tight so it can be pulled out. The cath-
eter is then stabilizedusingmultipleVicryl sutures to the right
pericardium tominimize dislodgment. Silk sutures are placed
to secure the catheter at the skin exit site (Figures 1-5).
Initial LA pressure is recorded together with the
preimplantation right-sided filling pressures (Figure 6).
After implantation of the HeartMate II device and during
cardiopulmonary bypass weaning, correlation of the
LA pressure and the LV unloading to the intraventricular
septal dynamics on transesophageal echocardiography
for a specific HeartMate II device speed is closely
monitored.A range ofwanted LApressures is then recorded,
and the patient is weaned from cardiopulmonary bypass.
In the intensive care unit, the desired range of LA
pressures established in the operating room is one of the
main hemodynamic parameters guiding therapy. Between
postoperative days 2 and 5 and after stabilization of the
patient’s hemodynamics, the LA pressure line is taken out.
Safe removal requires stable coagulation parameters andFIGURE 5. Tip of the Codman Microsensor (DePuy Co, Raynham,
Mass).
gery c April 2014
FIGURE 6. Left atrial line waveform (bottom, white).
Surgical Techniquestemporary increase in HeartMate II device flows to decrease
LA pressure and minimize bleeding into the pericardial
cavity. Early in our series, we had the tip of the catheter
dislodged in the pericardial cavity in 2 patients and 1 patient
had a suction event after pre-pull HeartMate II device
speed adjustment emptied the LV. After these initial
complications, we used guide catheters to prevent dis-
lodgement of the sensor tip. No bleeding or systemic
embolic complications related to this LAmonitoring system
have been noted in our series.
CONCLUSIONS
Our off-label LA pressure monitoring system using
a Codman Microsensor offers safe and reliable results with
minimal or no complications and should be implanted in
all patients requiring direct LA pressure monitoring.From the Cardiac Surgery Division,a Hospital Beneficencia Portuguesa de S~ao Paulo,
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Circulation. 1970;42:75-8.A technique for repair of partial anomalous pulmonary vein
connection to the superior vena cavaJose Pedro da Silva, MD,a Luciana da Fonseca da Silva, MD,a,b Cintia Acosta Melo, MD,a and
Lilian Maria Lopes, MD,a S~ao Paulo, BrazilThe repair of a partial anomalous pulmonary venous
connection (PAPVC) to the high superior vena cava(SVC) was simplified by the surgical procedure reported
by Warden et al1 in 1984. They described a technique that
consisted of dividing the SVC right above the anomalous
pulmonary vein, oversewing the lower SVC end, connect-
ing the SVC upper end to the right atrial appendage, and
placing an intra-atrial patch to complete the pulmonary
vein drainage to the left atrium through the atrial septal
defect. This ingenious Warden procedure prevents damage
to the sinus node and allows the involved anatomic
structures to grow. However, this operation has a limitation
for patients with a very high connection of the anomalous
pulmonary vein to the SVC. In such situations, the caval
division above the pulmonary vein entrance in the SVCdiovascular Surgery c Volume 147, Number 4 1427
